Clinical Trials Browser

Phase 2 × Lung Cancer Metastatic × 1 year × Clear all

NCT05144529 2026-05-05

TOP2101

Phase 2 Terminated

19 enrolled 16 charts

Lung Cancer Metastatic

NCT03057106 2026-03-03

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Phase 2 Active not recruiting

301 enrolled 15 charts

Lung Cancer Metastatic